Cannabinoids

"Cannabinoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.

Descriptor ID

D002186

MeSH Number(s)

D02.455.849.090

Concept/Terms

Cannabinoids

Below are MeSH descriptors whose meaning is more general than "Cannabinoids".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Terpenes [D02.455.849]
Cannabinoids [D02.455.849.090]

Below are MeSH descriptors whose meaning is related to "Cannabinoids".

Below are MeSH descriptors whose meaning is more specific than "Cannabinoids".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cannabinoids" by people in Harvard Catalyst Profiles by year, and whether "Cannabinoids" was a major or minor topic of these publication.

Bar chart showing 113 publications over 27 distinct years, with a maximum of 12 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	0	1	1
1998	1	0	1
2000	2	1	3
2001	4	1	5
2002	3	0	3
2003	2	0	2
2004	0	1	1
2005	0	1	1
2006	4	1	5
2007	2	0	2
2008	1	1	2
2009	3	0	3
2010	0	2	2
2012	5	0	5
2013	5	0	5
2014	4	1	5
2015	3	1	4
2016	2	2	4
2017	6	2	8
2018	6	2	8
2019	8	1	9
2020	2	3	5
2021	11	1	12
2022	8	0	8
2023	7	0	7
2024	1	0	1

Below are the most recent publications written about "Cannabinoids" by people in Profiles.

Human osteoclasts in vitro are dose dependently both inhibited and stimulated by cannabidiol (CBD) and ?9-tetrahydrocannabinol (THC). Bone. 2024 Apr; 181:117035.

View in: PubMed
False-Negative Confirmatory Testing in Patients With Cannabinoid-Positive Urine Drug Screens. JAMA Pediatr. 2024 Feb 01; 178(2):199-201.

View in: PubMed
Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201. Eur J Pharmacol. 2023 Dec 05; 960:176168.

View in: PubMed
Cannabis and cannabinoids in dermatology: protocol for a systematic review and meta-analysis of quantitative outcomes. BMJ Open. 2023 09 12; 13(9):e075007.

View in: PubMed
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial. Cells. 2023 07 08; 12(14).

View in: PubMed
Cannabinoid Therapy: Attitudes and Experiences of People With Chronic Pain. Clin J Pain. 2023 06 01; 39(6):249-258.

View in: PubMed
CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure. Sci Rep. 2023 04 11; 13(1):5869.

View in: PubMed
Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization. Clin Toxicol (Phila). 2023 04; 61(4):248-259.

View in: PubMed
Can we predict the treatment doses of THC and CBD and does it matter? Eur J Intern Med. 2023 06; 112:100-108.

View in: PubMed
Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice. J Neurosci. 2023 01 18; 43(3):373-385.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Pharmacol Exp Ther
Eur J Pharmacol
N Engl J Med
J Neurosci
Neuropharmacology
Nat Neurosci
Epilepsy Res
Drug Alcohol Depend
Behav Pharmacol
Br J Pharmacol